Use of ramipril in preventing stroke: double blind randomised trial

OBJECTIVE: To determine the effect of the angiotensin converting enzyme inhibitor ramipril on the secondary prevention of stroke. DESIGN: Randomised controlled trial with 2×2 factorial design. SETTING: 267 hospitals in 19 countries. PARTICIPANTS: 9297 patients with vascular disease or diabetes plus...

Celý popis

Podrobná bibliografie

Vydáno v:	BMJ
Hlavní autoři:	Bosch, Jackie, Yusuf, Salim, Pogue, Janice, Sleight, Peter, Lonn, Eva, Rangoonwala, Badrudin, Davies, Richard, Ostergren, Jan, Probstfield, Jeff
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2002
Témata:	Papers
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC99052/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11909785/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.324.7339.699
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!